medical device giant’s stock poised for growth By Investing.com
Medtronic PLC (BVMF:) (NYSE:MDT), a leading medical technology company, has been garnering increased attention from analysts as it navigates a period of consistent growth and operational improvements. Despite facing headwinds from foreign exchange impacts, the company’s solid organic sales growth and robust product pipeline have positioned it for potential accelerated earnings growth in the coming fiscal years.
Recent Performance and Financial Outlook
Medtronic (NYSE:) has demonstrated a consistent organic sales growth rate of 4-5% over the past year, showcasing the strength of its core business. This performance has been particularly noteworthy given the challenging macroeconomic environment. For the fiscal year 2025 (FY25), the…
